BiotechTube
Home/Cochlear/Dr. Robert (Bob) Klapper
DR

Dr. Robert (Bob) Klapper

Chief Technology Officer

Cochlear

Therapeutic Areas

Sensorineural Hearing LossConductive Hearing LossMixed Hearing LossSingle-Sided Deafness

Cochlear Pipeline

DrugIndicationPhase
Nucleus Platform EnhancementsSevere-to-Profound Sensorineural Hearing LossContinuous Development
Cochlear™ Acoustic Coil (CAC)Mixed Hearing LossClinical Evaluation
Nucleus® CI632 Slim Modiolar ElectrodeSevere-to-Profound Sensorineural Hearing LossCommercial
Osia System ExpansionConductive/Mixed Hearing Loss, Single-Sided DeafnessCommercial & Development
Telehealth & Remote Care SolutionsPatient Support & Clinical EfficiencyDevelopment & Deployment
Hearing Health Data & AIPerformance OptimizationResearch

Leadership Team at Cochlear

DH
Dig Howitt
Chief Executive Officer & President
SR
Simon R. Joyce
Chief Financial Officer
HH
Heidi Hemmer
Chief Commercial Officer
BL
Brett Lee
President, Cochlear Americas
PG
Professor Graeme Clark AC
Founder
DR
Dr. Rick Holliday-Smith
Chairman of the Board
View full Cochlear profile